Alarcón de la Lastra C, La Casa C, Martin M J, Motilva V
Departamento de Farmacología, Facultad de Farmacia, Universidad de Sevilla, Spain.
Inflamm Res. 1998 Mar;47(3):131-6. doi: 10.1007/s000110050301.
The aim of the present study was to examine the effects of cinitapride, a novel prokinetic benzamide-stimulating gastrointestinal motility agent, on gastric secretion and ulceration in rats and elucidate some possible vascular and anti-oxidant mechanisms of such protection.
Male Wistar rats.
Cinitapride (CNT, Lab. Almirall, S.A.) (0.25, 0.5, and 1 mg/kg) and 5-hydroxytryptamine (5-HT, Sigma Chemical Co., St. Louis, MO, USA) (10 mg/kg), administered intraperitoneally (i.p.).
Gastric ulceration was induced by instillation of 1 mL/100 g animal of 50% (v/v) ethanol in distilled water and by pylorus-ligated rat model. Gastric microvascular changes, and the activity of myeloperoxidase (as a marker of neutrophil infiltration) and glutathione peroxidase (an important enzyme in scavenging of lipid peroxides) were determined. The results were compared with those of 5-HT. The data were evaluated using Student's t-test for paired data and the non-parametric Mann-Whitney U-test.
In 4 h pyloric-ligated animals, i.p. CNT did not significantly reduce the incidence of gastric mucosal damage, and no significant differences were found in the values of total volume and acidity. However, CNT caused a marked and dose-dependent reduction of haemorrhagic lesions induced by 50% v/v ethanol. These protective effects were specifically related to a reduction of neutrophil infiltration. CNT at the dose of 1 mg/kg raised the decreased glutathione peroxidase activity to the control level. In contrast, pretreatment with 5-HT worsened the ethanol-induced erosions, but did not significantly induce any gastric microvascular changes. However, the myeloperoxidase activity rose markedly and the glutathione peroxidase levels decreased significantly in the mucosa injured by 50% v/v ethanol.
This study demonstrates a new gastroprotective feature of CNT that could be partly explained not only through reduction of neutrophil toxicity but also by an increased synthesis of free-radical scavenging enzymes such as glutathione peroxidase. Furthermore, it is likely that serotonergic-dependent mechanisms are also involved via 5-HT2-receptor blockade and 5-HT1 receptor activation.
本研究旨在考察新型促胃肠动力苯甲酰胺类药物西尼必利对大鼠胃分泌及溃疡形成的影响,并阐明这种保护作用可能涉及的一些血管及抗氧化机制。
雄性Wistar大鼠。
腹腔注射西尼必利(CNT,Almirall实验室,西班牙)(0.25、0.5和1 mg/kg)以及5-羟色胺(5-HT,Sigma化学公司,美国密苏里州圣路易斯)(10 mg/kg)。
通过向动物胃内灌注1 mL/100 g体重的50%(v/v)乙醇水溶液以及幽门结扎大鼠模型诱导胃溃疡形成。测定胃微血管变化、髓过氧化物酶活性(作为中性粒细胞浸润的标志物)以及谷胱甘肽过氧化物酶活性(清除脂质过氧化物的一种重要酶)。将结果与5-羟色胺组进行比较。采用配对数据的Student t检验和非参数Mann-Whitney U检验对数据进行评估。
在幽门结扎4小时的动物中,腹腔注射西尼必利未显著降低胃黏膜损伤的发生率,胃内容物总量及酸度值也未发现显著差异。然而,西尼必利能显著且剂量依赖性地减轻50%(v/v)乙醇诱导的出血性损伤。这些保护作用与中性粒细胞浸润的减少密切相关。1 mg/kg剂量的西尼必利可使降低的谷胱甘肽过氧化物酶活性恢复至对照水平。相反,5-羟色胺预处理会加重乙醇诱导的糜烂,但未显著引起任何胃微血管变化。然而,在50%(v/v)乙醇损伤的黏膜中,髓过氧化物酶活性显著升高,谷胱甘肽过氧化物酶水平显著降低。
本研究证实了西尼必利新的胃保护特性,这不仅可以部分通过减少中性粒细胞毒性来解释,还可以通过增加自由基清除酶如谷胱甘肽过氧化物酶的合成来解释。此外,通过5-HT2受体阻断和5-HT1受体激活,5-羟色胺依赖机制可能也参与其中。